These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 30924261)

  • 1. Differences in preventing new-onset cardiovascular events with statin therapy in seniors aged 75 years and over: A cohort study in the South Korean National Health Insurance Database.
    Kim K; Kwak A; Choi CU; Kim JH; Kim MG; Oh JM; Ji E
    Basic Clin Pharmacol Toxicol; 2019 Aug; 125(2):108-116. PubMed ID: 30924261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative effectiveness of statins in secondary prevention among the older people aged 75 years and over.
    Kwak A; Kim JH; Choi CU; Kim IW; Oh JM; Kim K
    Int J Clin Pharm; 2019 Apr; 41(2):460-469. PubMed ID: 30864086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of low- or moderate-intensity statin and ezetimibe vs. high-intensity statin monotherapy on primary prevention of cardiovascular disease and all-cause death: a propensity-matched nationwide cohort study.
    Jun JE; Jeong IK; Ahn KJ; Chung HY; Hwang YC
    Eur J Prev Cardiol; 2024 Aug; 31(10):1205-1213. PubMed ID: 38408362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative effectiveness of rosuvastatin versus simvastatin in primary prevention among new users: a cohort study in the French national health insurance database.
    Neumann A; Maura G; Weill A; Ricordeau P; Alla F; Allemand H
    Pharmacoepidemiol Drug Saf; 2014 Mar; 23(3):240-50. PubMed ID: 24292987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Moderate-intensity versus high-intensity statin therapy in Korean patients with angina undergoing percutaneous coronary intervention with drug-eluting stents: A propensity-score matching analysis.
    Park MW; Park GM; Han S; Yang Y; Kim YG; Roh JH; Park HW; Suh J; Cho YR; Won KB; Ann SH; Kim SJ; Kim DW; Her SH; Lee SG
    PLoS One; 2018; 13(12):e0207889. PubMed ID: 30532220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Persistence of atorvastatin and simvastatin among patients with and without prior cardiovascular diseases: a US managed care study.
    Foody JM; Joyce AT; Rudolph AE; Liu LZ; Benner JS
    Curr Med Res Opin; 2008 Jul; 24(7):1987-2000. PubMed ID: 18554430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patterns of Statin Use in a Real-World Population of Patients at High Cardiovascular Risk.
    Lin I; Sung J; Sanchez RJ; Mallya UG; Friedman M; Panaccio M; Koren A; Neumann P; Menzin J
    J Manag Care Spec Pharm; 2016 Jun; 22(6):685-98. PubMed ID: 27231796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative Effectiveness of Combination Therapy with Statins and Angiotensin-Converting Enzyme Inhibitors versus Angiotensin II Receptor Blockers in Patients with Coronary Heart Disease: A Nationwide Population-Based Cohort Study in Korea.
    Lee J; Lee S
    Pharmacotherapy; 2018 Nov; 38(11):1095-1105. PubMed ID: 30225928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Statin Therapy on the Risk of Intracerebral Hemorrhage in Korean Patients with Hyperlipidemia.
    Jung M; Lee S
    Pharmacotherapy; 2019 Feb; 39(2):129-139. PubMed ID: 30585646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular outcomes among patients newly initiating atorvastatin or simvastatin therapy: a large database analysis of managed care plans in the United States.
    Foody JM; Joyce AT; Rudolph AE; Liu LZ; Benner JS
    Clin Ther; 2008 Jan; 30(1):195-205. PubMed ID: 18343257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug utilization patterns and cardiovascular outcomes in elderly patients newly initiated on atorvastatin or simvastatin.
    Swindle JP; Potash J; Kulakodlu M; Kuznik A; Buikema A
    Am J Geriatr Pharmacother; 2011 Dec; 9(6):471-82. PubMed ID: 22019005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intensity of statin therapy and primary prevention of cardiovascular in Korean patients with dyslipidemia.
    Song SO; Kang MJ; Suh S
    Medicine (Baltimore); 2024 Mar; 103(11):e37536. PubMed ID: 38489707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term effect of statins on the risk of new-onset osteoporosis: A nationwide population-based cohort study.
    Lin TK; Chou P; Lin CH; Hung YJ; Jong GP
    PLoS One; 2018; 13(5):e0196713. PubMed ID: 29723231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular effect of discontinuing statins for primary prevention at the age of 75 years: a nationwide population-based cohort study in France.
    Giral P; Neumann A; Weill A; Coste J
    Eur Heart J; 2019 Nov; 40(43):3516-3525. PubMed ID: 31362307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative effectiveness of statin plus fibrate combination therapy and statin monotherapy in patients with type 2 diabetes: use of propensity-score and instrumental variable methods to adjust for treatment-selection bias.
    Suh HS; Hay JW; Johnson KA; Doctor JN
    Pharmacoepidemiol Drug Saf; 2012 May; 21(5):470-84. PubMed ID: 22461130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time-varying and dose-dependent effect of long-term statin use on risk of type 2 diabetes: a retrospective cohort study.
    Na E; Cho S; Kim DJ; Choi J; Han E
    Cardiovasc Diabetol; 2020 May; 19(1):67. PubMed ID: 32416728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical outcome of statin plus ezetimibe versus high-intensity statin therapy in patients with acute myocardial infarction propensity-score matching analysis.
    Ji MS; Jeong MH; Ahn YK; Kim SH; Kim YJ; Chae SC; Hong TJ; Seong IW; Chae JK; Kim CJ; Cho MC; Rha SW; Bae JH; Seung KB; Park SJ;
    Int J Cardiol; 2016 Dec; 225():50-59. PubMed ID: 27710803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statins for Prevention of Cardiovascular Events in a Low-Risk Population With Low Ankle Brachial Index.
    Ramos R; García-Gil M; Comas-Cufí M; Quesada M; Marrugat J; Elosua R; Sala J; Grau M; Martí R; Ponjoan A; Alves-Cabratosa L; Blanch J; Bolíbar B
    J Am Coll Cardiol; 2016 Feb; 67(6):630-640. PubMed ID: 26868687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Results of a Markov model analysis to assess the cost-effectiveness of statin therapy for the primary prevention of cardiovascular disease in Korea: the Korean Individual-Microsimulation Model for Cardiovascular Health Interventions.
    Kang HY; Ko SK; Liew D
    Clin Ther; 2009 Dec; 31(12):2919-30; discussion 2916-8. PubMed ID: 20110032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Statin use and outcome risks according to predicted CVD risk in Korea: A retrospective cohort study.
    Jung HH
    PLoS One; 2021; 16(1):e0245609. PubMed ID: 33450746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.